Evaluation compares serum amyloid A with established biomarkers for sepsis diagnosis, suggesting improved accuracy.
The application of SAA in the early diagnosis of sepsis holds substantial clinical promise, particularly when employed alongside established biomarkers such as PCT, CRP, and presepsin. This combinatory approach may enhance diagnostic accuracy.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: